comprehensive -WSS

comprehensive

author：leisure time 2025-10-01 00:17:23 - browse：79

There’s a specter haunting Wall Street.

It started in biotech, where companies making drugs for the obesity-related liver disease NASH saw their valuations crash on the assumption that GLP-1 weight loss treatments would cut them out of the market. Then the Ozempic panic came for dialysis firms, whose stocks fell about 20% in a single day on the news that Novo Nordisk’s medicine had delayed the progression of kidney disease in a study enrolling people with type 2 diabetes.

Now analysts from every sector are cranking out research notes on the disparate, dramatic, and often debatable implications of GLP-1 drugs’ growing popularity, said Jared Holz, a health care specialist at Mizuho Securities. Buy Bumble, sell McDonald’s. Short Pepsi, go long Louis Vuitton. Put your money in sectors that cater to a svelte and sated brand of consumer, and get out of the ones that rely on excess and compulsion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： FTX founder Sam Bankman

focus

WSS

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Readout LOUD podcast, live from the STAT Breakthrough Summit East

An Ebola outbreak presents a new mystery involving children

In venture capital firm's success, lessons for turning crisis into profit

FTX founder Sam Bankman

More regulation could be coming for drug ads

focus

comprehensive

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Medicare details structure of new drug price negotiation program

Biotech investment managers search for lucrative opportunities

Jerome Adams on the need for new antivirals for Covid

Erich Jarvis studies song birds to learn about human stuttering

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Cancer, immunology, HIV research ensnared in fetal tissue politics

DIEP, the 'gold standard' of breast reconstruction, is under threat

FTX founder Sam Bankman

hotspot

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

FTX founder Sam Bankman

An Ebola outbreak presents a new mystery involving children

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Discs beat pads, tampons for heavy menstrual flow, new study shows

Biden praises World Series champion Astros for impact off the field during White House celebration

hotspot

focus

hotspot

entertainment